noscript

News and Announcements

Bioactive Annual Update 2016; New Compounds & Fractions Discovered, New Substance Pre-Screening Passed & Commercial Relationships Formed

  • Published January 31, 2017 3:25PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Platform technology experts, Bioactive, continues to move forward with their capital raise along with achieving set targets during 2016:

  • Bioactive Therapeutics’, the Drug Discovery Division, has discovered new compounds and fractions to firmly establish a compound library within the key streams of inflammatory disorders and infectious diseases.
  • Bioactive Natural Health’, the Listed Medicine Division, has passed a rigorous TGA new substance pre-screening to proceed to full evaluation. Commercial relationships have been formed with some of the region’s largest companies and expect to be formalised to coincide with TGA approval in 2017.
  • These opportunities collectively service the global market of 7 billion people. An investor exit is planned within 2 years.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now